Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine:: Potential of the nanoparticulate cytosolic protein delivery carrier

被引:57
作者
Yoshikawa, Tomoaki [1 ,2 ]
Okada, Naoki [1 ,2 ]
Oda, Atsushi [1 ,2 ]
Matsuo, Kazuhiko [1 ,2 ]
Matsuo, Keisuke [1 ,2 ]
Mukai, Yohei [1 ]
Yoshioka, Yasuo [1 ,3 ]
Akagi, Takami [2 ,4 ]
Akashi, Mitsuru [2 ,3 ,4 ]
Nakagawa, Shinsaku [1 ,2 ,3 ]
机构
[1] Osaka Univ, Dept Biotechnol & Therapeut, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Japan Sci & Technol Agcy, CREST, Tokyo, Japan
[3] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan
[4] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan
关键词
nanoparticle; tumor vaccine; antigen presentation/processing; antigen-presenting cells;
D O I
10.1016/j.bbrc.2007.11.153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nanoscopic therapeutic systems that incorporate biomacromolecules, such as protein and peptides, are emerging as the next generation of nanomedicine aimed at improving the therapeutic efficacy of biomacromolecular drugs. In this study, we report that poly(gamma-glutamic acid)-based nanoparticles (gamma-PGA NPs) are excellent protein delivery carriers for tumor vaccines that delivered antigenic proteins to antigen-presenting cells and elicited potent immune responses. Importantly, gamma-PGA NPs efficiently delivered entrapped antigenic proteins through cytosolic translocation from the endosomes, which is a key process of gamma-PGA NP-mediated anti-tumor immune responses. Our findings suggest that the gamma-PGA NP system is suitable for the intracellular delivery of protein-based drugs as well as tumor vaccines. (C) 2007 Published by Elsevier Inc.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 15 条
[1]   Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(γ-glutamic acid)-graft-L-phenylalanine copolymers [J].
Akagi, T ;
Higashi, M ;
Kaneko, T ;
Kida, T ;
Akashi, M .
BIOMACROMOLECULES, 2006, 7 (01) :297-303
[2]   Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with L-phenylalanine as a protein carrier [J].
Akagi, T ;
Kaneko, T ;
Kida, T ;
Akashi, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (2-3) :226-236
[3]   In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(γ-glutamic acid) [J].
Akagi, T ;
Higashi, M ;
Kaneko, T ;
Kida, T ;
Akashi, M .
MACROMOLECULAR BIOSCIENCE, 2005, 5 (07) :598-602
[4]   Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives [J].
Akagi, Takami ;
Wang, Xin ;
Uto, Tomofumi ;
Baba, Masanori ;
Akashi, Mitsuru .
BIOMATERIALS, 2007, 28 (23) :3427-3436
[5]   ANTIGEN PRESENTATION TO CYTOTOXIC T-LYMPHOCYTES IN-VIVO [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :639-641
[6]   Particulate delivery systems for biodefense subunit vaccines [J].
Bramwell, VW ;
Eyles, JE ;
Alpar, HO .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (09) :1247-1265
[7]  
HARDING CV, 1994, J IMMUNOL, V153, P4925
[8]   DELIVERY OF EXOGENOUS ANTIGEN INTO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I AND CLASS-II PATHWAYS BY ELECTROPORATION [J].
LI, Y ;
KE, Y ;
GOTTLIEB, PD ;
KAPP, JA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (05) :616-624
[9]   An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow [J].
Lutz, MB ;
Kukutsch, N ;
Ogilvie, ALJ ;
Rössner, S ;
Koch, F ;
Romani, N ;
Schuler, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 223 (01) :77-92
[10]   Syntaxin 7 mediates endocytic trafficking to late endosomes [J].
Nakamura, N ;
Yamamoto, A ;
Wada, Y ;
Futai, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6523-6529